The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Share News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Lidco upbeat after 'excellent' second half performance

Thu, 13th Feb 2020 16:00

(Sharecast News) - Haemodynamic monitoring company Lidco updated the market on its just-ended financial year on Thursday, reporting that it continued to make progress with developing a strong recurring revenue base through its software-as-a-service (SaaS) high usage programme (HUP) model, and had achieved an "excellent" second half performance.
The AIM-traded firm said its product revenues for the 12 months ended 31 January were up 19% to ?7.4m, which was in line with management expectations.

It said the growth in Lidco product revenues "more than outweighed" the expected reduction in low margin third-party product sales.

As a result, total revenues, including third party products, were up 3% at ?7.6m, with the board explaining that the increased proportion of higher-margin Lidco revenues led to an increase in overall gross margin.

The company said it now had a global contracted base of 286 HUP monitors, up from 164 at the end of the 2019 financial year, generating total annualised contracted licence revenues of ?2.2m, which was an increase of 57%.

It said the 19% growth in 2020 financial year Lidco product sales reflected growth in all regions compared with the prior year.

Lidco product sales grew 28% in the United States to ?1.8m, 1% in the UK to ?3.6m, and sales outside of the firm's direct markets were up 60% to ?2.0m.

The directors said the "significant" growth outside the UK included ?0.4m growth in China from the launch of the new monitor, and as a result, sales outside the UK now represented "just over half" of Lidco product sales, up from 43% a year ago.

In the second half of the year there was a net cash inflow of ?0.2m, compared with a net cash outflow of ?0.5m in the first half.

The company said its balance sheet remained "strong", with cash balances as at 31 January totalling ?1.4m, down from ?1.7m, while the firm remained debt free.

Its board said it was expecting to report positive adjusted EBITDA for the 2020 financial year, compared to an EBITDA loss of ?1.2m in the 2019 financial year.

"After a strong first half in the 2020 financial year, the team succeeded in delivering an even better second half performance," said chief executive officer Matt Sassone.

"Our differentiated SaaS business model continues to drive our growth with the number of HUP monitors installed globally increasing nearly 75% and this has contributed to our expansion in recurring revenues."

Sassone said he was also pleased with the company's international sales growth, as it now had the majority of its Lidco product sales outside the UK, where it retained its market share and leadership position.

"This excellent performance leads to the expectation that we will report positive adjusted EBITDA for the 2020 financial year."

Lidco said it would announce its audited results for the year ended 31 January on 21 April.

At 1447 GMT, shares in Lidco were up 11.26% at 5.28p.
More News
6 Jun 2014 05:24

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Friday, June 6
Read more
5 Jun 2014 15:08

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Friday, June 6
Read more
5 Jun 2014 05:10

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Thursday, June 5
Read more
4 Jun 2014 15:29

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar
Thursday, June 5
Read more
21 May 2014 12:55

NantHealth completes communications link with LiDCO

AIM-listed medical group LiDCO announced US-based healthcare firm NantHealth has developed a communications link between LiDCO's blood analysis monitors and its DeviceConX system. NantHealth's software, DeviceConx, collects and transmits data from medical devices into an electronic record for docto

Read more
21 May 2014 11:48

LiDCO Group Monitors Link With NantHealth's Software System

LONDON (Alliance News) - LiDCO Group PLC said Wednesday said US-based NantHealth has successfully completed development of a proprietary communications link between LiDCO monitors and its own DeviceConX system. NantHealth's DeviceConX is a software solution that collects and transmits data

Read more
20 May 2014 14:56

LiDCO Says Results Of Study Using Its Cardiac Monitor Published

LONDON (Alliance News) - LiDCO Group PLC Tuesday said a recent study published in the Journal of American Medical Association found that perioperative hemodynamic intervention is associated with a reduced complication rate and length of stay in hospital after surgery. A test was conducted i

Read more
1 May 2014 10:53

LiDCO Says Study Supports Its Monitors For Post Surgery Programmes

LONDON (Alliance News) - LiDCO Group PLC Thursday noted a study that it said showed that an enhanced recovery after surgery programme using its haemodynamic monitors reduced length of hospital stay and incidences of urinary tract infections. The study, by the Enhanced Recovery Study Group a

Read more
29 Apr 2014 12:40

LiDCO Swings To Profit As Revenue Boosted By Strong UK Performance

LONDON (Alliance News) - LiDCO PLC Tuesday expressed confidence for 2014 after it swung to a pretax profit for 2013, as revenue was boosted by strong growth from its UK business. LiDCO produces cardiac monitoring equipment and disposables. LiDCO posted a pretax profit of GBP217,000, s

Read more
17 Mar 2014 13:11

LiDCO To Launch New Version Of LiDCOrapid Software

LONDON (Alliance News) - LiDCO Group PLC said Monday that it will be launching a new version of its LiDCOrapidv2 software at the International Symposium on Intensive Care and Emergency Medicine in Brussels. The conference, organised by the department of Intensive Care Emergency Medicine of

Read more
17 Mar 2014 12:49

CORRECT: UK MIDDAY BRIEFING: Housebuilders Lead FTSE 350 On More Help-To-Buy

(Correcting direction of FTSE 250 index.) LONDON (Alliance News) - Housebuilders lead a surprisingly upbeat UK equities market Monday, occupying six of the top ten spaces in the FTSE 350, buoyed by an extension to the UK government's Help to Buy scheme.

Chancellor George Osbor

Read more
17 Mar 2014 12:45

UK MIDDAY BRIEFING: Housebuilders Lead FTSE 350 On More Help-To-Buy

LONDON (Alliance News) - Housebuilders lead a surprisingly upbeat UK equities market Monday, occupying six of the top ten spaces in the FTSE 350, buoyed by an extension to the UK government's Help to Buy scheme.

Chancellor George Osborne confirmed that the government's flagship Help

Read more
17 Mar 2014 11:57

UK WINNERS & LOSERS: Housebuilders Jump; Supermarkets Fall Again

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Persimmon, up 4.7%. The housebuilder's share price has jumped following c

Read more
12 Mar 2014 15:45

Medical research boosts LiDCO hopes

An independent medical study proving the cost-effectiveness of monitoring bloodflow during surgery has been welcomed by AIM-listed LiDCO, whose equipment was used for the trials. Published data examining the cost effectiveness of post-operative goal-directed therapy (GDT), a surgical intervention t

Read more
12 Mar 2014 10:17

Study Supports LiDCO's Monitoring Equipment For Postoperative Therapy

LONDON (Alliance News) - LiDCO Group PLC said Wednesday that a study into the cost-effectiveness of Postoperative Goal-Directed Therapy proved that this type of care was both cost and clinically effective, supporting the use of its LiDCOplus monitoring equipment. The LiDCOplus monitor provi

Read more

Quickpicks are a member only feature

Login to your account